These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 25545600)
1. Amphetamine abuse as a rare cause of recurrent LVAD pump thrombosis. Heim C; Kondruweit M; Weyand M; Tandler R J Card Surg; 2015 Feb; 30(2):215-6. PubMed ID: 25545600 [TBL] [Abstract][Full Text] [Related]
2. Images in cardiovascular medicine. Repeated successful thrombolysis of a Jarvik 2000 left ventricular assist device in a patient with noncompaction cardiomyopathy. Ninios V; Visouli A; Pitsis A Circulation; 2010 Jan; 121(3):e13-4. PubMed ID: 20100979 [No Abstract] [Full Text] [Related]
3. Successful treatment of acute left ventricular assist device thrombosis and cardiogenic shock with intraventricular thrombolysis and a tandem heart. Agarwal R; Raina A; Lasorda DM; Moraca RJ; Bailey SH; Kanwar M; Sokos G; Murali S; Benza RL ASAIO J; 2015; 61(1):98-101. PubMed ID: 25248042 [TBL] [Abstract][Full Text] [Related]
5. Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. Kiernan MS; Pham DT; DeNofrio D; Kapur NK J Thorac Cardiovasc Surg; 2011 Sep; 142(3):712-4. PubMed ID: 21277594 [No Abstract] [Full Text] [Related]
6. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy. Thenappan T; Anderson AS; Jeevanadham V; Rich JD; Shah AP Circ Heart Fail; 2013 May; 6(3):e27-9. PubMed ID: 23694774 [No Abstract] [Full Text] [Related]
7. Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device. Schrage B; Grahn H; Wagner FM; Bernhardt A; Rybczynski M; Blankenberg S; Reichenspurner H; Barten MJ Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):766-770. PubMed ID: 28058856 [TBL] [Abstract][Full Text] [Related]
8. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. Delgado R; Frazier OH; Myers TJ; Gregoric ID; Robertson K; Shah NA; Kar B J Heart Lung Transplant; 2005 Feb; 24(2):231-3. PubMed ID: 15701444 [TBL] [Abstract][Full Text] [Related]
9. Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis. Jorde UP; Aaronson KD; Najjar SS; Pagani FD; Hayward C; Zimpfer D; Schlöglhofer T; Pham DT; Goldstein DJ; Leadley K; Chow MJ; Brown MC; Uriel N JACC Heart Fail; 2015 Nov; 3(11):849-56. PubMed ID: 26454842 [TBL] [Abstract][Full Text] [Related]
10. Advantages and disadvantages of using intravenous tissue Plasminogen activator as salvage therapy for inoperable HeartWare thrombosis. Basken R; Bazzell CM; Smith R; Janardhanan R; Khalpey Z J Card Surg; 2017 Jul; 32(7):443-446. PubMed ID: 28631345 [TBL] [Abstract][Full Text] [Related]
11. Systemic or Endoventricular Thrombolysis to Treat HeartWare Left Ventricle Assist Device Thrombosis: A Clinical Dilemma. Raffa GM; D'Ancona G; Sciacca S; Pietrosi A; Hernandez Baravoglia CM; Turrisi M; Romano G; Armaro A; Stringi V; Clemenza F; Pilato M Artif Organs; 2015 Jun; 39(6):526-9. PubMed ID: 25735566 [TBL] [Abstract][Full Text] [Related]
14. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches. Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475 [TBL] [Abstract][Full Text] [Related]
15. Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices. Gyoten T; Morshuis M; Rojas SV; Deutsch MA; Schramm R; Gummert JF; Fox H J Artif Organs; 2021 Jun; 24(2):173-181. PubMed ID: 33337536 [TBL] [Abstract][Full Text] [Related]
16. Limited Efficacy of Thrombolytics for Pump Thrombosis in Durable Left Ventricular Assist Devices. Seese L; Hickey G; Keebler M; Thoma F; Kilic A Ann Thorac Surg; 2020 Dec; 110(6):2047-2054. PubMed ID: 32348739 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics. Kamouh A; John R; Eckman P Ann Thorac Surg; 2012 Jul; 94(1):281-3. PubMed ID: 22734996 [TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy due to thrombus formation associated with left ventricular assist devices. Rothenburger M; Schmid C; Huelksen G; Loeher A; Scheld HH J Heart Lung Transplant; 2005 Dec; 24(12):2305. PubMed ID: 16364888 [No Abstract] [Full Text] [Related]
19. Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis. Upshaw JN; Kiernan MS; Morine KJ; Kapur NK; DeNofrio D ASAIO J; 2016; 62(1):33-9. PubMed ID: 26479464 [TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation. Webber BT; Panos AL; Rodriguez-Blanco YF Ann Card Anaesth; 2016; 19(1):192-6. PubMed ID: 26750701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]